No Data
No Data
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Raises Target Price to $12
GeoVax Labs (GOVX) Receives a Buy From Noble Financial
GeoVax Labs' Promising Vaccine Trials Enhance Buy Rating Amid Robust Immune Response and Market Potential
GeoVax Labs Announces Interim Data From Phase 2 Trial of Vaccine Technology
No Data
No Data
Quan Yin : GG is over.